More recently, Illopoulos et al. [22] arrived a similar conclusion supporting that tumor heterogeneity involves a dynamic equilibrium between stem and non- stem cell compartments and this plasticity is regulated by interlukin (IL)-6, the inflammatory cytokine that is known to induce the expression of TG2 in various cell types [23], [24]. The gene discussed is IL6; the disease is neoplasm.